Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reckitt Benckiser Plc ADR (OP: RBGLY )

12.03 -0.12 (-0.99%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Reckitt Benckiser Plc ADR

< Previous 1 2 Next >
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued. 
Via Benzinga
Exposures Product Safety
What You Missed On Wall Street This Past Friday
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 
Via Talk Markets
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation. 
Via Benzinga
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
Reckitt Benckiser is reportedly in early talks to sell its homecare division, featuring brands like Air Wick and Calgon, as part of a broader strategy to focus on consumer health and hygiene. The sale... 
Via Benzinga
Carlyle Pays $300M For Majority Ownership In India's VLCC
Via Benzinga
British Consumer Company Reckitt Benckiser's CEO Steps Down
Via Benzinga
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage. 
Via InvestorPlace
Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula
This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. federal or state courts. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
What's Going On With Abbott Laboratories Stock On Friday?
An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challenging due to strict regulatory oversight. 
Via Benzinga
NVDA Stock on Fire: Can Potential Nvidia Investors Still Get In or Will They Get Burned?
Nvidia could generate $100 billion in free cash flow over the next two years. That’s excellent news for Nvidia stock. 
Via InvestorPlace
Reckitt's Mead Johnson Initiates Massive Recall Of 675K Cans Of Hypoallergenic Baby Formula Over Bacteria Contamination Fears
A massive recall of hypoallergenic infant formula has been initiated due to concerns over potential bacteria contamination. The recall involves approximately 675,000 cans of infant formula. 
Via Benzinga
Pumpkin Spice Profits: Take a Sip of SBUX Stock Before the End of the Year
Starbucks continues to deliver healthy growth across its operating regions. However, China is the key to SBUX stock. 
Via InvestorPlace
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Exposures Product Safety
3 Consumer Staples Stocks to Dump ASAP
There are plenty of strong, inflation-beating picks out there, so these three consumer staples stocks to sell are best left alone. 
Via InvestorPlace
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Via Benzinga
7 Established Stocks That Are Poised for Growth in 2023
The youngest of these stocks that are poised for growth in 2023 was founded in 1993. In other words, they are all established names. 
Via InvestorPlace
Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT). 
Via Benzinga
The Viral “Tripledemic” Opportunity
Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu... 
Via Talk Markets
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Via Benzinga
The “Procter & Gamble Of The UK” Is Now On My Watchlist
One of the larger companies in the UK, parts of which have been around for 200+ years, is Reckitt Benckiser Group plc. I like to think of it as the Procter & Gamble of the UK. 
Via Talk Markets
Short Volatility Alert: Reckitt Benckiser Group plc
On Friday, shares of Reckitt Benckiser Group plc (OTC: RBGLY) experienced volatile short activity. After the activity, the stock price went down -1.96% to $14.48. The overall sentiment for RGBLY has... 
Via Benzinga
New Starbucks CEO To Focus On Unions, Pay And Benefits As Part Of 'Reinvention' Plan
Starbucks Corporation (NYSE: SBUX) surprised everyone this week by naming Reckitt Benckiser Group plc (OTC: RBGLY) 
Via Benzinga
Why This Starbucks Analyst Is Surprised By New CEO Choice — And Optimistic
Starbucks Corporation (NYSE: SBUX) announced late Thursday the appointment of Reckitt Benckiser Group plc (OTC: RBGLY) top brass 
Via Benzinga
Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Via Benzinga
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
Reuters Monkeypox Emergency Could Last Months, According To Experts 
Via Benzinga
Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, May 25
Reuters Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims 
Via Benzinga
More Companies Join Race To Ease US Baby Formula Supply Crunch
Danone SA (OTC: DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.